The transcripts of SFRP1, CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder

被引:21
作者
Buim, ME
Soares, FA
Sarkis, AS
Nagai, MA
机构
[1] Univ Sao Paulo, Fac Med, Dept Radiol, Disciplina Oncol, BR-01246903 Sao Paulo, Brazil
[2] FMUSP, HC, Fundacao Antonio Prudente, Sao Paulo, Brazil
[3] FMUSP, HC, Dept Urol, Div Clin Urol, Sao Paulo, Brazil
关键词
bladder cancer; differential gene expression; SFRP1; EIF4G2; CEP63;
D O I
10.1159/000090984
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of the present study was to identify differentially expressed genes that might be associated with the phenotype of superficial and invasive bladder cancer. Methods: Differential display reverse transcriptase PCR ( DDRT-PCR) was used to compare the expression pattern between normal bladder tissue and 4 groups of transitional cell carcinomas of the bladder regarding clinical stage and grade. Results: We were able to identify 72 different transcripts, of which 57 (79%) showed homology to known genes, 12 (17%) to hypothetical proteins and 3 (4%) to human expressed sequence tags. Among the differentially expressed genes, SFRP1, CEP63 and EIF4G2 were further validated by quantitative RTPCR in a series of 50 transitional cell carcinomas. Overall, the transcripts of these three genes were shown to be downregulated in the bladder tumors analyzed. In accordance with the DDRT-PCR results, the SFRP1 transcripts were shown to be downregulated in 90% (45/50) of the bladder tumors as compared with the normal bladder tissue. Although EIF4G2 and CEP63 transcripts exhibited three different expression patterns, downregulation was found in about 50% of the cases analyzed. In addition, downregulation of both CEP63 and EIF4G2 gene transcription was associated with invasive tumors. Conclusion: The use of DDRT-PCR analysis to compare expression patterns among different subgroups of bladder tumors allowed us to identify a significant number of genes implicated in different cellular pathways that, when up- or downregulated, might play a role in the tumorigenic process of the bladder. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:445 / 454
页数:10
相关论文
共 53 条
  • [1] Proteomic characterization of the human centrosome by protein correlation profiling
    Andersen, JS
    Wilkinson, CJ
    Mayor, T
    Mortensen, P
    Nigg, EA
    Mann, M
    [J]. NATURE, 2003, 426 (6966) : 570 - 574
  • [2] Bane BL, 1996, SEMIN ONCOL, V23, P546
  • [3] IRESdb:: the internal ribosome entry site database
    Bonnal, S
    Boutonnet, C
    Prado-Lourenço, L
    Vagner, S
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (01) : 427 - 428
  • [4] Centrosome composition and microtubule anchoring mechanisms
    Bornens, M
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2002, 14 (01) : 25 - 34
  • [5] Managing the centrosome numbers game: from chaos to stability in cancer cell division
    Brinkley, BR
    [J]. TRENDS IN CELL BIOLOGY, 2001, 11 (01) : 18 - 21
  • [6] The Wnt antagonist sFRP1 in colorectal tumorigenesis
    Caldwell, GM
    Jones, C
    Gensberg, K
    Jan, S
    Hardy, RG
    Byrd, P
    Chughtai, S
    Wallis, Y
    Matthews, GM
    Morton, DG
    [J]. CANCER RESEARCH, 2004, 64 (03) : 883 - 888
  • [7] Translational control of gene expression and disease
    Calkhoven, CF
    Müller, C
    Leutz, A
    [J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (12) : 577 - 583
  • [8] AZU-1:: A candidate breast tumor suppressor and biomarker for tumor progression
    Chen, HM
    Schmeichel, KL
    Mian, IS
    Lelièvre, S
    Petersen, OW
    Bissell, MJ
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (04) : 1357 - 1367
  • [9] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [10] Crew JP, 2000, BRIT J CANCER, V82, P161